MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Pathophysiology"

  • 2019 International Congress

    Neurophysiologic characterization of Re-emergent tremor (RET) in Parkinson’s disease

    G. Leodori, D. Belvisi, A. Fabbrini, M. de Bartolo, M. Costanzo, F. Undurraga, A. Conte, A. Berardelli (Bethesda, MD, USA)

    Objective: To investigate: 1) the contribution of primary motor cortex (M1) to the generation of re-emergent tremor (RET) and rest tremor by measuring the Cortico-muscular…
  • 2019 International Congress

    GluRδ2 protein reduction in cerebellar Purkinje cells contributes to the pathogenesis of essential tremor

    MK. Pan, YS. Li, CL. Ni, WC. Liu, E. Cortes, JP. Vonsattel, E. Louis, P. Faust, SH. Kuo (Taipei, Taiwan)

    Objective: To identify a molecular substrate reflecting kinetic tremor, the core feature of essential tremor (ET) Background: ET is one of the most common movement…
  • 2018 International Congress

    Change of tremor dominant body side after deep brain stimulation in patients with Parkinson’s disease

    P. Wouters, M. Janssen, P. Kubben, L. Ackermans, Y. Temel, M. Kuijf (Maastricht, Netherlands)

    Objective: In this study, we aimed to determine changes in distribution of tremor dominant body side after DBS and searched for possible explanations if tremor…
  • 2018 International Congress

    Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson’s disease

    S. Qian, Y. Sheng, Z. Zhong (Nanjing, China)

    Objective: To examine plasma iron metabolism related indicators in patients with Parkinson’s disease (PD) and investigate the mechanism underlying the tremor-dominant phenotype of PD. Background:…
  • 2018 International Congress

    Distinguishing isolated asymmetric limb tremor from essential tremor: An electrophysiological study

    F. Gövert, J. Becktepe, F. Brugger, L. Rocchi, A. Garrido, B. Balint, R. Hannah, T. Walter, J. Rothwell, R. Elble, K. Bhatia, G. Deuschl (Kiel, Germany)

    Objective: The aim of this study was to investigate the somatosensory discrimination threshold (STDT), the short intracortical inhibition (SICI) and the cortical plasticity via paired…
  • 2018 International Congress

    Tremor in motor neuron disease may be central rather than peripheral in origin

    A. Latorre, L. Rocchi, M. Stamelou, A. Batla, M. Ciocca, B. Balint, K. Sidle, A. Berardelli, J. Rothwell, K. Bhatia (London, United Kingdom)

    Objective: To investigate the pathophysiology of action tremor in motor neuron disease (MND). Background: MND refers to a spectrum of degenerative diseases affecting motor neurons.…
  • 2018 International Congress

    Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson Disease

    H. Sanjari Moghaddam, F. Ghazi Sherbaf, M H. Aarabi, M. Mojtahed Zadeh (Tehran, Islamic Republic of Iran)

    Objective: This work was designed to investigate peripheral inflammation in terms of Neutrophil-Lymphocyte ratio (NLR) concerning loss of dopaminergic uptake in caudate and putamen on…
  • 2018 International Congress

    Microstructural Changes in Normal Appearing White Matter in Parkinson’s Disease (PD) Correlate with Motor, Tremor, and Neuropsychiatric Scores

    J. Kim, T. Baumeister, M. McKeown (Vancouver, BC, Canada)

    Objective: To determine if microstructural changes in the normal appearing white matter of PD are associated with clinical manifestations of disease. Background: White matter (WM)…
  • 2017 International Congress

    TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.

    Y. Maricich, E. Newbold, R. Elble (Charlottesville, VA, USA)

    Objective: We will study CX-8998, a selective Cav3 antagonist with safety data in 194 patients,  in the treatment of ET. Few large controlled ET trials…
  • 2017 International Congress

    Prism adaptation and cerebellar inhibition were impaired in essential tremor

    R. Hanajima, R. Tsutsumi, Y. Shirota, T. Shimizu, N. Tanaka, Y. Ugawa (Kanagawa, Japan)

    Objective: We aimed to reveal cerebellar dysfunction in patients with essential tremor using neurophysiological methods. Background: Cerebellar dysfunction is suggested to contribute to tremor generation.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley